KERX Shares Outstanding History



Below is a table of the KERX shares outstanding history going back to 3/15/2010:

Date KERX Shares Outstanding
3/15/201056.86M
5/5/201058.59M
8/3/201058.92M
10/29/201061.18M
2/24/201161.55M
5/9/201169.08M
8/1/201169.70M
10/31/201171.02M
2/23/201271.02M
5/2/201271.19M
7/31/201271.91M
10/31/201271.93M
2/26/201381.68M
4/30/201381.72M
7/24/201381.82M
10/25/201382.32M
3/1/201490.91M
5/1/201491.45M
7/30/201491.82M
10/31/201491.94M
2/17/2015103.60M
4/20/2015103.60M
7/22/2015105.17M
10/23/2015105.19M
2/22/2016105.88M
4/22/2016105.82M
7/29/2016105.90M
11/4/2016105.96M
2/22/2017107.67M
4/28/2017108.47M
7/20/2017118.75M
10/31/2017119.22M
2/9/2018119.18M
4/30/2018120.44M
7/31/2018120.46M
10/31/2018120.38M

Also see: KERX Market Cap History
KERX YTD Return
KERX Historical Shares Outstanding:
+9.07% CAGR
KERX Historical Shares Outstanding: +9.07% CAGR

Mouse over chart for data details
3/15/2010 ...10/31/2018
Keryx Biopharmaceuticals is a commercial stage biopharmaceutical company focused on bringing medicines to people with kidney disease. Co.'s marketed product, Auryxia (ferric citrate) tablets, is an orally available, absorbable, iron-based medicine. Auryxia is used for the control of serum phosphorus levels in patients with chronic kidney disease (CKD), on dialysis. Auryxia is also for the treatment of iron deficiency anemia in adults with CKD, not on dialysis. Ferric citrate is also approved in Japan under the trade name Riona and marketed by Co.'s Japanese partner, Japan Tobacco, Inc. and its subsidiary, Torii Pharmaceutical Co., Ltd., and approved in Europe as Fexeric. We show 36 historical shares outstanding datapoints in our coverage of KERX's shares outstanding history.

Understanding the changing numbers of KERX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like KERX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching KERX by allowing them to research KERX shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree KERX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Keryx Biopharmaceuticals (KERX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

KIDS Shares Outstanding History
KIN Shares Outstanding History
KLDO Shares Outstanding History
KMPH Shares Outstanding History
KND Shares Outstanding History
KNTE Shares Outstanding History
KOD Shares Outstanding History
KOOL Shares Outstanding History
KPRX Shares Outstanding History
KPTI Shares Outstanding History
More Healthcare companies »

 

KERX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.